What’s Happening With Seed And Series A Funding, In 4 Charts?

When venture funding started to turn south after a blockbuster year in 2021, seed and early-stage funding was at first relatively unscathed. Investment into seed startups globally actually grew in Q2 2022 , even as venture investment overall dropped off dramatically.
The size of a typical seed round also shrank, an analysis of Crunchbase data shows. After peaking in 2022 at $2.5 million, the median U.S. seed round dipped to $2.3 million in Q1 2023 . The average dipped slightly from $3.7 million to $3.6 million.
Series A round sizes also dipped. The median Series A for a U.S. startup was $12 million last quarter — down $2 million compared to the 2022 median. Average deal size dipped from $19.1 million in 2022 and 2021 to $18.7 million last quarter.
Still, last quarter’s typical Series A deals were double or triple their size in 2014.
And some massive Series A checks have gone to biotech startups and companies in the red-hot artificial intelligence space this year.
Paradigm , a clinical trials platform, raised a $203 million Series A round last quarter. Cargo Therapeutics, a biotech working on cancer treatments, raised $200 million. In AI, ChatGPT competitor Character.ai raised $150 million in a round led by Andreessen Horowitz that landed it on The Crunchbase Unicorn Board.
Seed funding starts to slip
Seed and angel investment to U.S. startups fell 45% year over year in the first quarter of 2023, to $3.1 billion, Crunchbase data shows. That’s the lowest quarterly amount since Q4 2020.
Series A tumbles
Series A is suffering too. Crunchbase data shows Series A investment into U.S.-based startups has fallen for five consecutive quarters, dwindling from $14.5 billion in Q4 2021 to $5.7 billion last quarter.
